ALEXANDRIA, Va., July 16 -- United States Patent no. 12,362,038, issued on July 15, was assigned to Travera Inc. (Medford, Mass.).
"Identifying cancer therapies" was invented by Rob Kimmerling (Cambridge, Mass.), Selim Olcum (Cambridge, Mass.), Clifford Reid (Pacifica, Calif.) and Mark Stevens (Cambridge, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "In silico tools are used to determine possibly effective therapies for treating a patient's cancer based on patient, drug, and cancer information. Functional assays can be performed on living cancer cells from the patient to evaluate the possibly effective therapies along with subsequent genomic or other more destructive assays to provide additional infor...